Introduction
============

In the eukaryotic genome, protein kinases comprise one of the largest families of proteins (Manning et al., [@B63]) and together with their counteracting protein phosphatases, they regulate a common post-translational modification observed in intracellular signaling. Activation of protein kinases and phosphatases typically occurs in response to extracellular stimuli as well as to intracellular stresses, and the resulting changes in the phosphorylation state of proteins lead to specific cellular responses (Cohen, [@B19]; Moorhead et al., [@B67]; Pidoux and Tasken, [@B76]). Eukaryotic kinases themselves often require activation by phosphorylation (Nolen et al., [@B71]) and are distinguished by their target residue specificities, which for the purposes of this review are either serine/threonine or tyrosine residues (Olsen et al., [@B72]; Moorhead et al., [@B67]; Pidoux and Tasken, [@B76]). Changes in the phosphorylation state have a broad impact on the cell, altering many processes such as the subcellular localization of proteins, the activity, or substrate specificity of enzymes, as well as specific protein--protein interactions. Furthermore, signals can be amplified within the cell by a cascade of substrate phosphorylation events, while fine-tuning and temporal control can be modulated by opposing phosphatases. This interplay allows spatial and temporal separation of intracellular signaling (Cohen, [@B19]; Moorhead et al., [@B67]; Pidoux and Tasken, [@B76]; Scott and Pawson, [@B83]).

Cellular processes that rely on phosphorylation have been extensively described in prokaryotes and eukaryotes and include transcription, translation, transport and energy flux, cell cycle, phagocytosis, and the innate immune response to pathogens (Manning et al., [@B63],[@B64]; Ryan and Shapiro, [@B81]; Lindmo and Stenmark, [@B57]; Back et al., [@B4]). In order to ensure a proper balance between the unphosphorylated and the phosphorylated state of proteins, tight regulation of protein kinases, and phosphatases is of crucial importance for the cell and imbalance often results in aberrant signaling leading to disease (Manning et al., [@B64]).

Interference with the host phosphorylation machinery is a common strategy used by pathogens to promote growth and survival in host tissues. For instance, the gastric pathogen *Helicobacter pylori* directs host cell cytoskeletal rearrangements by delivery of the CagA protein into host cells (Covacci et al., [@B20]; Segal et al., [@B85], [@B84]; Backert et al., [@B5]; Stein et al., [@B90]). Following translocation into the cell, CagA is phosphorylated by Src host tyrosine kinases and subsequently induces changes in cell morphology due to cytoskeleton rearrangement (Segal et al., [@B85]; Stein et al., [@B90]). Src kinases along with the host focal adhesion kinase are activated as a result of the interaction of the bacterial CagL protein with the integrin α~5~β~1~ receptor (Kwok et al., [@B53]). Therefore, *H. pylori* proteins can both activate and serve as substrates for host kinases.

Many intracellular pathogens exploit the host phosphorylation machinery by interfering with phosphoinositide (PI) metabolism and thereby target a major signaling pathway controlling membrane trafficking, actin rearrangement, and cell survival (Toker and Cantley, [@B93]; De Matteis and Godi, [@B23]; Krauss and Haucke, [@B50]; Duronio, [@B24]; Weber et al., [@B98]). Phosphatidylinositol 3-kinases (PI3Ks) play a major role in signal transduction during phagocytosis and therefore in the uptake of many pathogens (Ireton et al., [@B42]; Toker and Cantley, [@B93]; Lindmo and Stenmark, [@B57]; Weber et al., [@B98]). *Listeria monocytogenes* is one such pathogen that is internalized in a PI3K-dependent fashion, as 3-phosphorylated phosphatidylinositol phosphates are required for cytoskeletal rearrangements involved in this process (Ireton et al., [@B42]; Mostowy and Cossart, [@B68]). *Mycobacterium tuberculosis* controls PI metabolism in a different fashion, forcing entry into a replication compartment that has a low phosphatidylinositol-3-phosphate \[PI(3)P\] content. This association appears to be linked with evasion of the lysosomal network, as PI(3)P is a key component of early endosomes that mature into endolysosomes (Lindmo and Stenmark, [@B57]; Philips, [@B75]). One of the strategies utilized by *Mycobacteria* to keep the PI(3)P content low in the membrane surrounding the replication compartment involves the secretion of PI, protein, and lipid phosphatases (Vergne et al., [@B94]; Beresford et al., [@B10]). *M. tuberculosis* proteins, therefore directly target phosphorylation events associated with host PI metabolism.

Similar to *M. tuberculosis*, the intracellular pathogen *Legionella pneumophila* resides and replicates within a specialized vacuole in the host cytosol (Horwitz, [@B34],[@B35]; Horwitz and Maxfield, [@B37]). The proper formation of this replication vacuole relies on the Icm/Dot type IV secretion system (Marra et al., [@B65]; Berger et al., [@B11]; Segal et al., [@B86]; Vogel et al., [@B96]). Up to 200 bacterial proteins are translocated into the cytosol, targeting a variety of host pathways contributing to efficient intracellular growth of *L. pneumophila* (Burstein et al., [@B16]; Huang et al., [@B40]). Characterized translocated proteins are known to target ER → Golgi membrane trafficking (Murata et al., [@B69]; Ingmundson et al., [@B41]; Machner and Isberg, [@B62]), modulate host cell survival (Laguna et al., [@B54]; Banga et al., [@B6]), or inhibit the eukaryotic translation elongation complex (de Felipe et al., [@B22]; Belyi et al., [@B8], [@B9]).

In this review we discuss selected host phosphorylation pathways that are targeted by *L. pneumophila* during interactions with host cells. The strategies used by the microorganism include translocation of kinases that directly manipulate host cell phosphorylation, but also include indirect effects that result in alteration of host cell signaling in response to formation of the *L. pneumophila* replication vacuole.

*L. pneumophila* Protein Kinases and Phosphatases
=================================================

While *M. tuberculosis* has both kinases and phosphatases that directly impact host signal transduction controlled by phosphorylation (Walburger et al., [@B97]; Vergne et al., [@B94]; Beresford et al., [@B10]), of the close to 200 known and putative Icm/Dot translocated substrates (Burstein et al., [@B16]; Huang et al., [@B40]) none show sequence similarity to known phosphatases or tyrosine kinases. Four translocated proteins, LegK1, LegK2, LegK3, and LegK4 contain domains that show homology to eukaryotic Ser/Thr kinases (de Felipe et al., [@B22], [@B21]; Bruggemann et al., [@B14]; Shin et al., [@B89]; Hervet et al., [@B33]). Of the LegK homologs, LegK1 and LegK2 are the best characterized. As is the case with the majority of translocated substrates, LegK1 is dispensible for intracellular growth in bone marrow-derived macrophages isolated from A/J mice and in the environmental host *Acanthamoeba castellanii* (de Felipe et al., [@B22]; Losick et al., [@B59]). LegK1 exhibits kinase activity *in vitro* and it has been proposed that it interferes with the host innate immune system by directly activating the NF-κB pathway, because ectopic expression of the protein in mammalian cells results in activation of an NF-κB-dependent promoter (Ge et al., [@B30]; Losick et al., [@B59]). The kinase activity is necessary for this activation, as a point mutation in the ATP binding domain or a catalytic residue abolishes NF-κB activity (Ge et al., [@B30]; Losick et al., [@B59]). *In vitro*, NF-κB activation by LegK1 occurs through direct phosphorylation of a component in the signaling cascade, the inhibitor IκB, resulting in degradation of the inhibitor and release of NF-κB into the host cell nucleus (Ge et al., [@B30]). Whether or not LegK1-mediated phosphorylation of IκB plays a role in NF-κB activation during macrophage challenge by *L. pneumophila* is unclear, as a *legK1* deletion mutant is able to efficiently activate an NF-κB regulated promoter (Losick et al., [@B59]). The role of LegK1 during growth within the natural host ameba is similarly unclear, as there are no known NF-κB orthologs in any sequenced amebal species.

As is true with LegK1 (Ge et al., [@B30]), LegK2 exhibits protein kinase activity *in vitro*, however its specific host target is not known (Hervet et al., [@B33]). In the amebal host *A. castellanii*, LegK2 activity plays some role in the recruitment of the ER marker calnexin and is required during early time points of intracellular replication, as a *legK2* deletion mutant displays a delayed onset of growth (Hervet et al., [@B33]). Less is known about the functions of LegK3 and LegK4. LegK3 has been studied in the context of NF-κB activation and the mitogen-activated protein kinase (MAPK) pathway, but failed to show an impact on either (Shin et al., [@B89]; Ge et al., [@B30]). Regarding their expression during bacterial growth in broth as well as during infection of *A. castellanii*, the LegK homologs share a similar pattern. In post-exponential phase the expression of LegK1-4 is slightly reduced in the *L. pneumophila* Lens isolate (Hervet et al., [@B33]) and during host cell infection, expression levels of all four genes do not significantly change (Bruggemann et al., [@B15]).

Compared to other pathogens, such as pathogenic *Yersinia* species, which have well characterized kinases and phosphatases that have impact on the disease process (Viboud and Bliska, [@B95]; Ribet and Cossart, [@B80]), less is known about *L. pneumophila* proteins that directly change the phosphorylation state of host targets during infection. As will be illustrated below, *L. pneumophila* appears to modulate host cell phosphorylation pathways indirectly, via processes associated with the uptake and replication of *L. pneumophila*.

Host Phosphatases and kinases Targeted During *L. pneumophila* Infection
========================================================================

To obtain a comprehensive understanding of which host cell pathways are necessary for intracellular growth of *L. pneumophila*, the global transcriptional host cell response has been investigated by several groups, using mouse bone marrow-derived macrophages, human macrophage-like cell lines and amebae (Farbrother et al., [@B26]; Losick and Isberg, [@B60]; Abu-Zant et al., [@B1]; Shin et al., [@B89]; Li et al., [@B56]; Fontana et al., [@B27]). These data were complemented by chemical genetics to identify host factors that are essential for the early steps of infection and for Icm/Dot-dependent protein translocation into a macrophage cell line (Charpentier et al., [@B17]). The latter approach provided substantial knowledge of the host factors necessary for phagocytosis of *L. pneumophila* and Icm/Dot substrate translocation including PI3Ks (see below). In the natural host amebae, besides inducing a stress response, major transcriptional changes occurred at various time points of *L. pneumophila* challenge, including increased transcription of aminoacyl-tRNA synthetases and decreased expression of ribosomal protein genes (Farbrother et al., [@B26]; Li et al., [@B56]). In human macrophage-like cells, encounter with *L. pneumophila* also resulted in increased transcription of stress response genes, however, the most striking transcriptional response in mammalian cells was demonstrated to be the upregulated expression of genes encoding components of the innate immune system (Losick and Isberg, [@B60]; Shin et al., [@B89]). In human macrophage-like cells these included genes regulated by NF-κB, genes encoding anti-apoptotic proteins as well as dual specificity phosphatases (DUSPs) known to be negative regulators of the MAPK pathway (Losick and Isberg, [@B60]). The transcriptional profile of murine bone marrow-derived macrophages also showed enhanced transcription of *dusp* genes (Shin et al., [@B89]). These transcriptional responses were specific to virulent *L. pneumophila*, since they were dependent on the presence of a functional Icm/Dot system.

The transcriptional analyses as well as the application of chemical genetics indicate that the host cell response to *L. pneumophila* involves differential regulation of a variety of signaling cascades that are controlled by phosphorylation and dephosphorylation. The following sections will focus on different stages of the infection cycle and the impact of host kinases and phosphatases on these pathways (Figure [1](#F1){ref-type="fig"}).

![**The host phosphorylation system is targeted during different stages of *L. pneumophila* encounter with host cells**. **(A)** The initial contact and subsequent uptake into the host cell is thought to be dependent on PI3Ks and respective downstream signaling in macrophages (Tachado et al., [@B91]; Charpentier et al., [@B17]). **(B)** Alterations in PI levels at the vacuole contribute to differential protein recruitment and could interfere with endocytic trafficking to vacuole (Weber et al., [@B100], [@B99]; Ragaz et al., [@B79]; Brombacher et al., [@B13]). **(C)** After contact with cells of higher eukaryotes, the NF-κB pathway is activated, which alters cytokine production, host cell survival, and intracellular replication of *L. pneumophila* (Losick and Isberg, [@B60]; Abu-Zant et al., [@B1]; Shin et al., [@B89]; Bartfeld et al., [@B7]; Fontana et al., [@B27]). **(D)** The MAPK signaling pathway is also modulated during infection and proper regulation is necessary for *L. pneumophila* replication in amebae and cytokine production in macrophages (Welsh et al., [@B101]; Losick and Isberg, [@B60]; Shin et al., [@B89]; Li et al., [@B56]).](fmicb-02-00064-g001){#F1}

Host factors involved in phagocytosis and establishing a replication compartment
--------------------------------------------------------------------------------

Each cycle of infection starts with uptake of *L. pneumophila* into the host cell by phagocytosis. Uptake into human alveolar macrophages under non-opsonized conditions has been documented to occur by coiling phagocytosis (Horwitz, [@B36]; Charpentier et al., [@B17]). The mechanism of phagocytosis of *L. pneumophila*, however, has been a point of dispute for some time, with the role of PI3Ks being a particular focus of controversy. As mentioned above, pathogens may be taken up in a PI3K-dependent manner (Weber et al., [@B98]). Activation of PI3K leads to downstream signaling events that involve synthesis of PI(3,4,5)P~3~, which is likely to be followed by recruitment of guanidine nucleotide exchange factors that activate Rho family GTPases involved in regulation of actin rearrangements (Lindmo and Stenmark, [@B57]).

The role of PI3Ks during phagocytosis of *L. pneumophila* appears to differ between host systems, bacterial strains, and the experimental setup used (see below). Initially, it was postulated that uptake of virulent *L. pneumophila* JR32 (Philadelphia-1) into U937 human macrophage-like cells does not depend on PI3Ks (Khelef et al., [@B49]). Phagocytosis of *L. pneumophila* having an intact Icm/Dot system was not blocked by the PI3K inhibitor wortmannin, and this failure to inhibit uptake was independent of the opsonization conditions used. When actin polymerization was visualized at *L. pneumophila* entry sites, there appeared to be no affect of inhibitors of PI3K function. However, a mutant having an inactivated Icm/Dot system was taken up in a PI3K-dependent manner indicating that the presence of a functional protein translocation system targets *L. pneumophila* into a unique uptake pathway (Khelef et al., [@B49]).

In the ameba *Dictyostelium discoideum*, inhibition of PI3Ks by wortmannin and LY294002 reduced the uptake of *L. pneumophila* (Weber et al., [@B100]; Peracino et al., [@B74]). In spite of this reduction in uptake, deletion of class I PI3Ks appeared to have a positive influence on intracellular replication (Weber et al., [@B100]; Peracino et al., [@B74]). Deletion of genes encoding PI3Ks, as well as chemical inhibition of their activities, changes the morphology of the replication vacuole and it was postulated that this structure might stimulate intracellular replication (Weber et al., [@B100]). The absence of PI3Ks could result in an altered composition of PIs at the *Legionella*-containing vacuole (LCV) causing changes in host protein recruitment. Also, improved intracellular replication could be due to enhanced bypass of the endocytic pathway, which requires PI3K activity, and may compete for sequestration of the microorganism into a compartment that is restrictive for intracellular growth (Lindmo and Stenmark, [@B57]; Weber et al., [@B100]).

Besides PI3Ks, another enzyme involved in PI metabolism, the inositol polyphosphate-5-phosphatase Dd5p4, influences *L. pneumophila* infection in *D. discoideum*. Host cells lacking Dd5p4 showed a defect in uptake, but once internalized, the bacteria showed improved intracellular replication, which is similar to the phenotype observed for loss of PI3K (Weber et al., [@B100], [@B99]). Dd5p4 is recruited to the LCV in a Icm/Dot-dependent manner and is catalytically active, which putatively leads to conversion from PI(4,5)P~2~ to PI(4)P (Weber et al., [@B99]). PI(4)P is considered a lipid marker for the LCV, that serves as an anchor for Icm/Dot substrates and is detectable at the LCV dependent on the presence of an intact Icm/Dot system (Weber et al., [@B100]; Ragaz et al., [@B79]; Brombacher et al., [@B13]). As in amebae, PI(4)P is also found at the LCV in infected RAW264.7 murine macrophage cells indicating that intracellular replication within ameba and mammalian cells has similar lipid requirements (Weber et al., [@B100]). Furthermore, the human homolog of Dd5p4, OCRL1, which plays a role in trafficking from endosomes to the *trans*-Golgi network (Lowe, [@B61]), could also be detected at the LCV and likely functions similarly to Dd5p4 during intracellular replication (Weber et al., [@B99]). Therefore, targeting of PI metabolism seems to occur at different stages of the infectious cycle following uptake and contributes to proper establishment of the LCV (Figure [2](#F2){ref-type="fig"}).

![**Targeting of host cell PI metabolism by *L. pneumophila***. (1) Depending on the model system, uptake into the host cell may require PI3K signaling (Khelef et al., [@B49]; Weber et al., [@B100]; Tachado et al., [@B91]; Charpentier et al., [@B17]; Peracino et al., [@B74]). (2) To properly establish the LCV, *L. pneumophila* interferes with host vesicle trafficking. Changes in the composition of PIs at the LCV might contribute to altered trafficking (Weber et al., [@B100], [@B99]; Isberg et al., [@B43]). (3) Changes in the PI levels at the vacuole may help *L. pneumophila* to avoid the endocytic pathway (Lindmo and Stenmark, [@B57]; Weber et al., [@B100], [@B98]). (4) Throughout intracellular growth, PIs at the LCV likely provide scaffolding for both *L. pneumophila* translocated proteins and host proteins (Weber et al., [@B100], [@B99]; Ragaz et al., [@B79]; Brombacher et al., [@B13]).](fmicb-02-00064-g002){#F2}

The notion that PI3Ks do not play a major role in uptake of *L. pneumophila* was challenged by a study using the J744A.1 murine macrophage cell line (Tachado et al., [@B91]). In the J744A.1 murine macrophage cell line, phagocytosis of *L. pneumophila* AA100 (Wadsworth) was reduced more severely by the PI3K inhibitors wortmannin and LY294002 than had been reported with other cell lines (Khelef et al., [@B49]; Weber et al., [@B100]; Peracino et al., [@B74]). In addition, cells expressing a dominant-negative mutant of PI3K were also depressed for uptake of the wild type *L. pneumophila* strain. Consistent with a role for PI3K during uptake, a downstream signal of PI3K activation, protein kinase B, was activated after challenge with *L. pneumophila*. Induction of the PI3K pathway could only be observed after contact with *L. pneumophila* expressing an intact Icm/Dot system (Tachado et al., [@B91]). One explanation for the conflicting results is that the J744A.1 cell line supports lower levels of *L. pneumophila* growth than other cell lines. Perhaps in cells in which there is luxurious intracellular growth of the bacterium, uptake is independent of PI3Ks. However, we have observed that wortmannin inhibits uptake of *L. pneumophila* into permissive mouse macrophages and it has been reported that uptake of *L. pneumophila* is reduced after treatment of *D. discoideum* with PI3K inhibitors (Weber et al., [@B100]; Peracino et al., [@B74]). There may be subtle differences in cytoskeletal regulatory circuits that determine whether PI3K is involved in uptake in different cell types.

A chemical genetics screen to find host cell functions required for Icm/Dot-dependent substrate translocation also supports the model that PI3Ks are involved in phagocytosis, at least in the J744A.1 cell line (Charpentier et al., [@B17]). In this study, phagocytosis was found to be a crucial prerequisite for Icm/Dot-promoted protein translocation (Charpentier et al., [@B17]). Inhibitors of either actin polymerization or PI3K reduced both Icm/Dot-dependent protein translocation and bacterial uptake. Taken together these data indicate that signaling through PI3K plays an important role during phagocytosis in these models.

Other novel targets identified by the chemical genetics screen pointed to the importance of tyrosine phosphatases for phagocytosis of *L. pneumophila* (Charpentier et al., [@B17]). The functionally redundant receptor protein tyrosine phosphate phosphatases CD45 and CD148 together with other, as yet unidentified, tyrosine phosphatases were shown to modulate uptake. Uptake of *L. pneumophila* into bone marrow-derived macrophages isolated from mice lacking CD45 and CD148 was drastically impaired compared to wild type macrophages, without affecting bacterial adhesion to cells. A more severe reduction in uptake relative to the mutant macrophages was observed in the presence of the CD45 inhibitor RWJ-60475, indicating that additional phosphatases may be involved. These results hint at a novel role of tyrosine phosphate phosphatases in phagocytosis of *L. pneumophila*. This is particularly interesting in light of the fact that there have been few convincing demonstrations that tyrosine phosphatases stimulate phagocytosis, other than the report that the tyrosine phosphatase Shp-1 stimulates *Neisseria* uptake (Hauck et al., [@B31]). Generally, tyrosine phosphatase activity has been connected to interference with uptake, as exemplified by the *Yersinia* YopH tyrosine phosphatase (Adkins et al., [@B2]).

Activation of the NF-κB pathway
-------------------------------

After phagocytosis, *L. pneumophila* resides within a membrane-bound compartment in the host cytosol. Consequently, survival of the host cell is necessary for successful replication. One way to prevent cell death involves direct interference of pro-death pathways by Icm/Dot translocated substrates (Laguna et al., [@B54]; Banga et al., [@B6]). A second mechanism of preventing host cell death during infection is to exploit proteins that are under the control of the mammalian transcription factor NF-κB, which acts as a positive regulator of genes encoding anti-apoptotic proteins (Karin and Lin, [@B47]). NF-κB homo- and heterodimers are master regulators of the mammalian innate immune response that control the expression of almost 400 genes (Karin and Lin, [@B47]; Ahn and Aggarwal, [@B3]; Hayden and Ghosh, [@B32]). NF-κB activation can result from sensing of pathogen associated molecular patterns (PAMPs; for example flagellin or peptidoglycan) by pattern recognition receptors (PRRs) that include the membrane-bound toll-like receptors (TLRs) and intracellular nod-like receptors (NLRs; Fritz et al., [@B28]; Kawai and Akira, [@B48]). Activation of these receptors triggers a signaling cascade that results in nuclear translocation of NF-κB subunits (Hayden and Ghosh, [@B32]). Signaling downstream from NLRs involves Rip2 kinase whereas TLR signaling is mediated via the adaptor proteins MyD88 and Trif (Shaw et al., [@B88]; Kawai and Akira, [@B48]). Both pathways lead to activation of IκB kinases (IKKs) by phosphorylation. Once activated, IKK phosphorylates IκB family members, resulting in degradation of these inhibitory proteins that are bound to the canonical NF-κB subunits in the cell cytoplasm (Hayden and Ghosh, [@B32]). Degradation of IκB frees the NF-κB subunits to be translocated into the nucleus (Hayden and Ghosh, [@B32]). The NF-κB pathway is manipulated by different pathogens such as *H. pylori* and *Rickettsia rickettsii* as well as by *L. pneumophila* (Clifton et al., [@B18]; Brandt et al., [@B12]). Challenge of host cells with *L. pneumophila* results in increased Icm/Dot-dependent transcription of NF-κB subunits as well as NF-κB regulated genes including pro-inflammatory cytokines and antagonists of apoptosis (Losick and Isberg, [@B60]; Abu-Zant et al., [@B1]; Shin et al., [@B89]; Bartfeld et al., [@B7]; Fontana et al., [@B27]).

There are probably multiple mechanisms that lead to NF-κB activation during *L. pneumophila* infection. Besides the engagement of PRRs with PAMPs, direct targeting of the pathway by Icm/Dot translocated substrates, such as LegK1 has been proposed, as pointed out above (Ge et al., [@B30]). NF-κB activation by *L. pneumophila* is probably more complex than can be explained by the action of a single effector, and likely occurs via the synergistic interaction of PRR signaling in combination with Icm/Dot-dependent components (Losick and Isberg, [@B60]; Shin et al., [@B89]; Bartfeld et al., [@B7]). At face value, PRR signaling and Icm/Dot activation of NF-κB appear to have different temporal courses of action, with PRR signaling occurring with more rapid kinetics than observed for Icm/Dot activation of the pathway (Bartfeld et al., [@B7]). It is unclear, however, if Icm/Dot activation of NF-κB ever occurs totally independently of PRR signaling. In macrophages from mice lacking TLR signaling via MyD88 and Nod signaling via Rip2, there appears to be little Icm/Dot-dependent signaling (Shin et al., [@B89]), although the presence of either PRR pathway is sufficient to support Icm/Dot-dependent NF-κB activation. This argues that although neither the type of bacterial ligand nor its site of encounter within the host cell are important for signaling, there is a requirement for the host cell to sense a PAMP for there to exist a strong Icm/Dot-dependent response.

In the human alveolar epithelial cell line A549, it has been shown that NF-κB activation follows a biphasic pattern. Short-term activation, measured by NF-κB nuclear translocation, depends on TLR5 and MyD88 (Bartfeld et al., [@B7]). This is followed by a TLR-independent long-term activation for which a functional Icm/Dot system is required. In concert with the data on synergy, these cells still retain Nod signaling, which could facilitate the Icm/Dot-dependent response. During long-term activation, IκB is degraded and anti-apoptotic genes are expressed (Bartfeld et al., [@B7]). Induction of anti-apoptotic genes appears to be the common theme in different host cell types (Losick and Isberg, [@B60]; Abu-Zant et al., [@B1]). The importance of host cell survival to maintain efficient intracellular replication was demonstrated in A/J bone marrow-derived macrophages. Inhibition of NF-κB caused increased host cell death in response to *L. pneumophila* challenge. However, the presence of NF-κB enhanced cell survival and was necessary for efficient replication (Losick and Isberg, [@B60]). Furthermore, one of the NF-κB regulated antagonists of apoptosis had a direct positive influence on host cell survival. In bone marrow macrophages derived from mice lacking plasminogen activator inhibitor-2 (PAI-2), there was increased cell death in response to *L. pneumophila* challenge (Losick and Isberg, [@B60]).

In bone marrow-derived macrophages from A/J mice, *L. pneumophila* activates NF-κB via at least two pathways depending on the multiplicity of infection. At low dose infections, there is little nuclear translocation of NF-κB in the absence of Icm/Dot, indicating that PRR recognition is not sufficient to give a robust signal (Losick and Isberg, [@B60]). For these low dose infections, NF-κB nuclear translocation is still observed in the absence of MyD88 and Trif, but relies on Icm/Dot (Losick and Isberg, [@B60]; Losick et al., [@B59]), and presumably Nod signaling, based on the work from the Roy lab (Shin et al., [@B89]). At an elevated multiplicity of infection, however, MyD88-dependent NF-κB activation can be observed in the absence of Icm/Dot (Losick and Isberg, [@B60]).

The data on Nod signaling adds complexity to formulating models on NF-κB signaling, but the basic message is consistent with the idea that as long as at least one PRR signaling pathway is intact, an Icm/Dot-dependent signal can be detected. It is clear that in bone marrow-derived macrophages capable of TLR signaling, Icm/Dot-dependent activation of NF-κB occurs in the absence of Nod1 or Rip2, even under conditions of low multiplicity challenge with *L. pneumophila* (Losick and Isberg, [@B60]; Losick et al., [@B59]). However, in HEK293T cells, which do not express TLRs that efficiently engage *L. pneumophila*, knockdown of Nod1 reduces NF-κB activation (Losick et al., [@B59]). These results complement results indicating that Icm/Dot-dependent NF-κB activation in the absence of MyD88 is only seen when Rip2 is present (Shin et al., [@B89]). Therefore, crosstalk between Icm/Dot translocated substrates and PAMP signaling must exist, but the source of the PAMP or the site in the cell that PAMP signaling is initiated do not appear to be critical (Losick et al., [@B59]). TLR engagement acts together with Icm/Dot in cells lacking Rip2 signaling, while similarly, Nod signaling collaborates with Icm/Dot in cells that lack the TLR pathway. This indicates that in the case of collaboration with Icm/Dot, the NLR, and TLR pathways could be redundant.

The significant impact of Icm/Dot on the activation of NF-κB led to two investigations to identify translocated substrates that could directly induce activation of this protein. NF-κB can be stimulated as a response to many different cellular insults, with ER stress and disruption of the actin cytoskeleton being two important examples (Nemeth et al., [@B70]; Ahn and Aggarwal, [@B3]; Schroder, [@B82]). Using similar approaches, two laboratories have identified Icm/Dot translocated substrates that are able to induce an NF-κB reporter when ectopically expressed in HEK293T cells. As described above, LegK1 was one of these substrates (Ge et al., [@B30]). In addition, there were a number of activators that showed modest activation of the reporter (Ge et al., [@B30]; Losick et al., [@B59]) as well as another strong inducer, the translocated substrate LnaB (Losick et al., [@B59]). When bacteria are grown into post-exponential phase, LnaB was shown to be required to fully activate the NF-κB reporter after challenge of HEK293T cells with *L. pneumophila* (Losick et al., [@B59]). The C-terminal coiled coil domain of LnaB was required for NF-κB induction. This suggests that this domain of LnaB interacts with a protein in the signaling cascade upstream of NF-κB or it may contribute to a cellular activity that increases NF-κB signaling. However, the role of LnaB in a cellular process leading directly or indirectly to NF-κB activation is not known (Losick et al., [@B59]). Although there is no evidence that LegK1 induces NF-κB after *L. pneumophila* challenge (Losick et al., [@B59]), as described above, *in vitro* experiments demonstrate a direct interaction with the signaling cascade upstream of NF-κB (Ge et al., [@B30]), and its pathway of activation could be very different from that observed with LnaB.

Besides LnaB and LegK1, five Icm/Dot translocated inhibitors of host translation exhibited NF-κB inducing activity accompanied by a distinctive transcriptional response including *IL23a* and *Csf2* induction (Fontana et al., [@B27]). It is possible that many Icm/Dot translocated substrates may lead to activation of the NF-κB pathway via a stress response rather than directly modulating the activity of proteins that regulate the nuclear translocation of this protein. The *L. pneumophila* proteins Lgt1, Lgt2, Lgt3, SidI, and SidL are known to cause an inhibition of host translation. This interferes with the synthesis of the unstable IκB inhibitory protein, which releases cytoplasmic NF-κB, allowing subsequent translocation into the nucleus (Hayden and Ghosh, [@B32]; Fontana et al., [@B27]). This inhibition of host protein synthesis caused by Icm/Dot substrates appears to be a key to causing sustained activation of NF-κB that can synergize with either TLR or Rip2-dependent signaling, as a *L. pneumophila* mutant lacking several translocated substrates that act as protein synthesis inhibitors is defective for NF-κB activation (Fontana et al., [@B27]; Figure [3](#F3){ref-type="fig"}).

![**Activation of NF-κB during *L. pneumophila* infection**. In addition to PRR mediated activation, Icm/Dot translocated substrates induce NF-κB by multiple mechanisms. During induction of the NF-κB pathway, the inhibitor IκB is phosphorylated by IKK and degraded, leading to nuclear translocation of the transcription factor (Hayden and Ghosh, [@B32]). Five Dot/Icm translocated substrates are known to target this pathway by inhibiting host translation (Fontana et al., [@B27]). This inhibition of translation interferes with the synthesis of the unstable inhibitor IκB and frees NF-κB subunits to translocate into the nucleus (Hayden and Ghosh, [@B32]; Fontana et al., [@B27]). The Ser/Thr kinase LegK1 has the ability to act directly on the NF-κB pathway by phosphorylating IκB (Ge et al., [@B30]), resulting in its degradation. The translocated protein LnaB activates NF-κB by an as yet unknown mechanism (Losick et al., [@B59]).](fmicb-02-00064-g003){#F3}

MAP kinases and dual specificity phosphatases
---------------------------------------------

In addition to the NF-κB pathway, which is only found in multicellular eukaryotes, the MAP kinase pathway is a second component of the innate immune system that is targeted during *L. pneumophila* infection (Welsh et al., [@B101]; Losick and Isberg, [@B60]; Shin et al., [@B89]; Li et al., [@B56]). The natural amebal hosts employ the MAP kinase pathway, so there is good reason to believe that selective pressures for effective interaction with MAP kinases must have taken place to facilitate intracellular replication of the bacterium. MAPKs regulate diverse cellular processes such as gene expression, cytoskeletal integrity, cell death, mitosis, and the induction of inflammatory mediators (Johnson and Lapadat, [@B46]; Jeffrey et al., [@B45]; Pullikuth and Catling, [@B78]; Huang et al., [@B39]). A cascade of sequentially active kinases, MAPKKKs and MAPKKs, activate MAPKs by threonine and tyrosine phosphorylation (Johnson and Lapadat, [@B46]; Huang et al., [@B39]). Activated MAPKs in turn phosphorylate specific substrates such as transcription factors, other kinases, or cytoskeletal proteins (Johnson and Lapadat, [@B46]). The four best characterized families of MAPKs found in higher eukaryotes, ERK, JNK, p38, and ERK5 respond to various stimuli, and are activated by specific MAPKKKs, resulting in both signal and target-specific responses (Johnson and Lapadat, [@B46]; Huang et al., [@B39]). MAPK signaling can be induced by activation of TLRs or NLRs as well as other stress response signals (Johnson and Lapadat, [@B46]; Huang et al., [@B39]). Linkage of NLRs to MAPKs occurs via Rip2 and Card9 while TLR signaling to MAPKs is MyD88-dependent (Hsu et al., [@B38]; Liu et al., [@B58]; Ting et al., [@B92]).

In order to ensure a proper balance of activation, MAPKs are regulated on a variety of levels including elaborate feedback loops and spatial separation of signaling (Jeffrey et al., [@B45]). After activation by the MAP kinase relay, inactivation occurs by dephosphorylation of Thr and Tyr residues of MAPKs by DUSPs (Lang et al., [@B55]; Jeffrey et al., [@B45]). DUSP family members are under tight control both at the transcriptional level and by post-translational modifications (Patterson et al., [@B73]) and in order to ensure specific targeting of MAPKs, they differ in their expression pattern and cellular localization (Lang et al., [@B55]; Jeffrey et al., [@B45]). Despite these differences, a common feature of many DUSPs is their transcriptional activation downstream from MAPK signaling, providing important feedback control of MAPK activation. In addition to transcriptional control, DUSP protein stability is influenced by MAPKs (Jeffrey et al., [@B45]).

Unlike the NF-κB pathway, MAPKs are also found in lower eukaryotes such as yeast and ameba (Molina et al., [@B66]). *D. discoideum* contains two enzymes similar to the mammalian ERK family (Gaskins et al., [@B29]; Segall et al., [@B87]). In *D. discoideum*, ERK-1 is phosphorylated shortly after *L. pneumophila* challenge with either a wild type or a Icm/Dot-deficient mutant (Li et al., [@B56]). This activation is transient with peak activation 1-h post infection. Inactivation of ERK-1 most likely relies on the tyrosine kinase/dual specificity phosphatase DupA, as there is constitutive activation of the MAPK in strains lacking DupA. The correct temporal regulation of ERK-1 activation has a significant impact on intracellular growth and host gene expression. In a mutant lacking DupA, intracellular replication of *L. pneumophil*a is impaired, and this accompanied by hyperphosphorylation of ERK-1 relative to wild type amebae (Li et al., [@B56]). The resulting transcriptional response in cells having hyperactivated ERK-1 included over 500 misregulated genes that were also impacted in wild type amebae after challenge with *L. pneumophila*. Interestingly, these genes include those encoding proteins hypothesized to play a role in the amebal response to pathogens (Li et al., [@B56]).

As in amebae, MAPK activation was also observed as a response to infection in murine bone marrow-derived macrophages (Shin et al., [@B89]). Here, ERK is activated independently of Icm/Dot and in the absence of the TLR signaling. Activation of p38 and SAPK/JNK follows a different pattern from mammalian ERK and is composed of an initial MyD88-dependent, Icm/Dot-independent component, as well as a delayed prolonged MyD88-independent component that relies on Icm/Dot. The kinetic data are reminiscent of MAPK activation in amebae, in that p38 and SAPK/JNK activation peaks at 1-h post infection and continues for 4 h. The high and sustained MAPK activity in response to *L. pneumophila* is necessary for increased cytokine production and requires MyD88-dependent, Icm/Dot-independent and MyD88-independent, Icm/Dot-dependent signaling. As Icm/Dot is required to fully activate MAPK signaling it was proposed that translocated substrates may play a role in this process. This idea was supported by data showing that the pore forming activity of the type IV secretion system alone is not sufficient to activate p38 and SAPK/JNK (Shin et al., [@B89]). Signaling through p38 and SAPK/JNK may involve Icm/Dot substrates that directly target the MAPK pathway or substrates that exhibit inducing activity by acting on a different host process and thereby indirectly activate MAPKs (Figure [4](#F4){ref-type="fig"}). However, the most likely Icm/Dot substrates containing Ser/Thr kinase domains, LegK1, Legk2, and LegK3, could be excluded as direct p38 activators (Shin et al., [@B89]). As described for NF-κB induction (Fontana et al., [@B27]), Icm/Dot translocated substrates that inhibit host protein synthesis could also explain the Icm/Dot-dependent mechanism of MAPK activation.

![**Mechanisms of MAPK activation during *L. pneumophila* infection**. MAPKs are activated by sequentially induced kinases and in turn phosphorylate cellular and nuclear proteins such as transcription factors (Johnson and Lapadat, [@B46]; Huang et al., [@B39]). Inactivation of MAPKs results from dephosphorylation by dual specificity phosphatases (DUSPs; Lang et al., [@B55]; Jeffrey et al., [@B45]). DUSPs are regulated on many levels to ensure proper signaling through MAPKs, and MAPKs themselves can control DUSPs at the level of transcription and protein stability (Jeffrey et al., [@B45]). During *L. pneumophila* challenge of host cells, induction of the MAPK signaling pathway occurs through PRR signaling as well as by Icm/Dot-dependent activity in macrophages, and via unidentified sensors in amebae (Shin et al., [@B89]; Li et al., [@B56]). Whether Icm/Dot translocated substrates target kinases upstream of MAPK, or, whether interference with protein synthesis is sufficient to alter MAPK activity, is unknown (Shin et al., [@B89]).](fmicb-02-00064-g004){#F4}

As observed with DupA in amebae, DUSPs also play a role during infection in mammalian cells. An Icm/Dot-dependent increase in transcription of *dusp* genes was observed in the human macrophage-like U937 cell line (Losick and Isberg, [@B60]). In mouse bone marrow-derived macrophages, it was shown that Icm/Dot-dependent induction of *dusp1* transcription did not require MyD88 or Rip2 kinase (Shin et al., [@B89]). Since *dusp* transcription is upregulated by MAPKs, this increase might be due to enhanced MAPK activity during infection. However, an increase of DUSP protein levels that would be expected to accompany increased transcription of the gene could not be observed, perhaps because of the presence of the *L. pneumophila* translocated substrates that interfere with protein synthesis in the host cell.

Mitogen-activated protein kinase activation appears to be a common response to *L. pneumophila* infection in lower and higher eukaryotes. Even though a direct participation of *L. pneumophila* proteins in MAPK activation seems likely, so far no Icm/Dot substrate was shown to act directly on the MAPK pathway. Concerning the function of DUSPs in regulating MAPKs during infection, the requirement of DUSPs to ensure proper balance of MAPK signaling is obvious from results in *D. discoideum*, as misregulation of ERK-1 interferes with intracellular growth of the bacterium (Li et al., [@B56]). The role of DUSPs in mammalian cells is not clear, however, especially since the induction of gene expression does not appear reflected in increased protein levels of DUSPs. In fact, the Icm/Dot-dependent induction of *dusp* transcription may be the result of MAPK activation caused by interference of host protein synthesis by *L. pneumophila*, so both transcriptional induction, and the lack of a translational response, are promoted by the same translocated substrates. *Dusp* expression is no longer elevated as a response to *L. pneumophila* infection in the absence of the five Icm/Dot translocated inhibitors of host translation, Lgt1, Lgt2, Lgt3, SidI, and SidL.

Concluding Remarks
==================

*Legionella pneumophila* is known to interfere with many host cell processes such as the ubiquitination machinery (Kubori et al., [@B51], [@B52]; Ivanov and Roy, [@B44]; Ensminger and Isberg, [@B25]; Price et al., [@B77]), host translation (de Felipe et al., [@B22]; Belyi et al., [@B8], [@B9]), or vesicle trafficking (Murata et al., [@B69]; Ingmundson et al., [@B41]; Machner and Isberg, [@B62]). Here we have presented a selected overview of targeted host cell pathways that mediate signal transduction through changes in the phosphorylation state of proteins and lipids. As phosphorylation and dephosphorylation are among the most common modifications in cell signaling, *L. pneumophila* exploits host phosphorylation at all stages of infection. Targeting of the host phosphorylation machinery may involve direct modification of host factors by *L. pneumophila* proteins that act as kinases or phosphatases as well as sensing of cellular processes during infection that indirectly change the phosphorylation state of host proteins. In the case of PI metabolism, the importance of controlling flux and recruitment of this important lipid during intracellular replication in amebae was clearly demonstrated (Weber et al., [@B100], [@B99]; Ragaz et al., [@B79]; Brombacher et al., [@B13]; Peracino et al., [@B74]), whereas the role of PI3Ks during uptake of *L. pneumophila* is not yet resolved and differs depending on the model system (Khelef et al., [@B49]; Weber et al., [@B100]; Tachado et al., [@B91]; Charpentier et al., [@B17]; Peracino et al., [@B74]). The requirement of Icm/Dot translocation for NF-κB and MAPK activation implies that translocated substrates contribute to these regulatory changes in host cells. Besides the inducing activity of inhibitors of host translation, no other mechanism for this activation has been proposed based on *in vivo* studies, so in the future it will be very interesting to determine what other factors induce these pathways apart from PRR signaling. With the emerging knowledge on the function of Icm/Dot translocated substrates, details regarding how *L. pneumophila* manipulates major signaling pathways involving phosphorylation should be forthcoming shortly.
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